104 related articles for article (PubMed ID: 11761950)
21. Hepatocellular carcinoma developing at the puncture site after percutaneous ethanol injection.
Almeida J; Mesquita M; Ferraz J; Yamanaka A; Escanhoela C; Boin IF; Pereira G; Pereira T; Soares E
J Clin Ultrasound; 2008 Feb; 36(2):105-7. PubMed ID: 17960825
[TBL] [Abstract][Full Text] [Related]
22. [Assessment of hepatocarcinoma treated with percutaneous ablation].
Lencioni R; Paolicchi A; Armillotta N; Cioni D; Donati F; Bartolozzi C
Radiol Med; 1998 May; 95(5 Suppl 1):53-8. PubMed ID: 9687904
[No Abstract] [Full Text] [Related]
23. Differentiation of hepatic tumors by color Doppler imaging: role of the maximum velocity and the pulsatility index of the intratumoral blood flow signal.
Kudo M; Tochio H; Zhou P
Intervirology; 2004; 47(3-5):154-61. PubMed ID: 15383724
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional power Doppler ultrasonography for demonstrating associated arteries of hepatocellular carcinoma.
Liang JD; Yang PM; Liang PC; Huang GT; Sheu JC; Chen DS
J Formos Med Assoc; 2003 Jun; 102(6):367-74. PubMed ID: 12923588
[TBL] [Abstract][Full Text] [Related]
25. [A color Doppler ultrasonographic study on patients with middle and late-stage liver cancer treated by transcatheter arterial chemoembolization].
Zhang XL; Shi Y; Chen Z; Zhou YX; Tian JK; Su Y; Dong Z
Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):566-7. PubMed ID: 14552729
[No Abstract] [Full Text] [Related]
26. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis.
Ignee A; Weiper D; Schuessler G; Teuber G; Faust D; Dietrich CF
Z Gastroenterol; 2005 Mar; 43(3):289-94. PubMed ID: 15765302
[TBL] [Abstract][Full Text] [Related]
27. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
[TBL] [Abstract][Full Text] [Related]
28. Power Doppler sonography: evaluation of hepatocellular carcinoma after treatment with transarterial embolization or percutaneous ethanol injection therapy.
Koito K; Namieno T; Ichimura T; Hirokawa N; Syonai T; Hareyama M; Katsuramaki T; Hirata K; Nishi M
AJR Am J Roentgenol; 2000 Feb; 174(2):337-41. PubMed ID: 10658701
[TBL] [Abstract][Full Text] [Related]
29. Color Doppler sonography in hepatocellular carcinoma.
Ralls PW; Johnson MB; Lee KP; Radin DR; Halls J
Am J Physiol Imaging; 1991; 6(2):57-61. PubMed ID: 1651094
[TBL] [Abstract][Full Text] [Related]
30. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
[TBL] [Abstract][Full Text] [Related]
31. [Tissue diagnosis with Doppler ultrasound].
Blank W; Braun B
Bildgebung; 1995 Apr; 62 Suppl 1():31-5. PubMed ID: 7670298
[No Abstract] [Full Text] [Related]
32. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis.
Fracanzani AL; Burdick L; Borzio M; Roncalli M; Bonelli N; Borzio F; Maraschi A; Fiorelli G; Fargion S
Hepatology; 2001 Dec; 34(6):1109-12. PubMed ID: 11731999
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of blood flows inside hepatic tumors using color Doppler echography with galactose-based intravenous contrast medium "SH/TA 508" administration].
Ishii M; Kawauchi A; Sakamoto M; Sasaki K; Kumano Y; Nishida H; Mukai T; Kusano M
Nihon Rinsho; 1998 Apr; 56(4):975-9. PubMed ID: 9577619
[TBL] [Abstract][Full Text] [Related]
34. [Therapeutic effect of TAE in patients with hepatocellular carcinoma using color Doppler imaging with intravenous ultrasound contrast agent].
Kimura M; Sato M; Shioyama Y; Hagihira T; Horihata K; Terada M; Kishi K; Tanaka K; Kawai N
Nihon Igaku Hoshasen Gakkai Zasshi; 2000 May; 60(6):320-3. PubMed ID: 10860382
[TBL] [Abstract][Full Text] [Related]
35. [Incidence of hepatocellular carcinoma increases. The obese are especially endangered].
Füessl HS
MMW Fortschr Med; 2004 Oct; 146(44):8. PubMed ID: 15566237
[No Abstract] [Full Text] [Related]
36. Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma.
Maruyama H; Ebara M
Int J Clin Oncol; 2006 Aug; 11(4):258-67. PubMed ID: 16937299
[TBL] [Abstract][Full Text] [Related]
37. [Clinical evaluation of power Doppler sonography for the diagnosis of hepatocellular carcinoma].
Ohishi H; Hirai T; Yamada R; Hirohashi S; Honda N; Sakaguchi H; Matsuo N; Uchida H
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 May; 56(6):399-404. PubMed ID: 8710463
[TBL] [Abstract][Full Text] [Related]
38. Differential diagnosis of small hepatocellular carcinoma and adenomatous hyperplasia with power Doppler sonography.
Koito K; Namieno T; Morita K
AJR Am J Roentgenol; 1998 Jan; 170(1):157-61. PubMed ID: 9423624
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or =2 cm.
Xu HX; Xie XY; Lu MD; Liu GJ; Xu ZF; Zheng YL; Liang JY; Chen LD
J Clin Ultrasound; 2008 Jun; 36(5):257-66. PubMed ID: 18088056
[TBL] [Abstract][Full Text] [Related]
40. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
